Advanced search
Publication Cover
Leukemia & Lymphoma Volume 55, 2014 - Issue 5
Submit an article Journal homepage
176
Views
10
CrossRef citations to date
0
Altmetric
Research Article

Health care utilization and risk of infection and bleeding among patients with myelodysplastic syndromes with/without transfusions, and with/without active therapy

B. Douglas SmithSidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD, USACorrespondence[email protected]
,
Dalia MahmoudCelgene Corporation, Summit, NJ, USA
,
Stacey Dacosta-ByfieldOptum, Eden Prairie, MN, USA
&
Virginia M. RosenOptum, Eden Prairie, MN, USA
Pages 1119-1125 | Received 21 Feb 2013, Accepted 23 Jun 2013, Published online: 28 Aug 2013

Citations (10)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Shaloo Gupta, Austin G. Kulasekararaj, Halley Costantino, Jay Grisolano, Jackson Tang, Shalon Jones & Derek Tang. (2023) Physicians’ experience in blood supply shortages and the top factors that impact the clinical, economic, and humanistic outcomes of patients with myelodysplastic syndromes in 5 European countries. Current Medical Research and Opinion 39:2, pages 239-247.
Read now

Articles from other publishers (9)

Lee Mozessohn, Qing Li, Ning Liu, Brian Leber, Dina Khalaf, Mitchell Sabloff, Grace Christou, Karen Yee, Lisa Chodirker, Anne Parmentier, Mohammed Siddiqui, Alexandre Mamedov, Liying Zhang, Ying Liu, Craig C. Earle, Matthew C. Cheung, Nicole Mittmann & Rena Buckstein. (2023) Impact of Frailty on Health Care Resource Utilization and Costs of Care in Myelodysplastic Syndromes. JCO Oncology Practice.
Crossref
Shaloo Gupta, Austin G. Kulasekararaj, Halley Costantino, Jay Grisolano, Jackson Tang, Shalon Jones & Derek Tang. (2022) Association between transfusion status and clinical and economic outcomes in patients with myelodysplastic syndromes from the physicians' perspective. Cancer Reports 6:1.
Crossref
Valeria Santini, Aristoteles Giagounidis, Christopher G. Pelligra, Conrado Franco-Villalobos, Derek Tang, Jessica Morison, CL Beach, Angela Hu, Uwe Platzbecker & Pierre Fenaux. (2022) Impact of Lenalidomide Treatment on Overall Survival in Patients With Lower-Risk, Transfusion-Dependent Myelodysplastic Syndromes. Clinical Lymphoma Myeloma and Leukemia 22:9, pages e874-e883.
Crossref
Shaima Kaka, Ashkan Jahangirnia, Nickolas Beauregard, Alexandra Davis, Alan Tinmouth & Nicolas Chin‐Yee. (2021) Red blood cell transfusion in myelodysplastic syndromes: A systematic review. Transfusion Medicine 32:1, pages 3-23.
Crossref
Amer M Zeidan, Tehseen Salimi & Robert S Epstein. (2021) Real-world use and outcomes of hypomethylating agent therapy in higher-risk myelodysplastic syndromes: why are we not achieving the promise of clinical trials?. Future Oncology 17:36, pages 5163-5175.
Crossref
Mayra Braga Lemos, Sarah Ramalho Rodrigues, Thomas Schroeder, Austin G. Kulasekararaj, Joana E. Matos & Derek Tang. (2021) Association between red blood cell transfusion dependence and burden in patients with myelodysplastic syndromes: A systematic literature review and meta‐analysis. European Journal of Haematology 107:1, pages 3-23.
Crossref
Jill A. Bell, Aaron Galaznik, Marlo Blazer, Huai-Che Shih, Eileen Farrelly, Augustina Ogbonnaya, Michael Eaddy, Robert J. Fram & Douglas V. Faller. (2018) Economic Burden of Patients Treated for Higher-Risk Myelodysplastic Syndromes (HR-MDS) in Routine Clinical Care in the United States. PharmacoEconomics - Open 3:2, pages 237-245.
Crossref
Corrado Girmenia, Anna Candoni, Mario Delia, Roberto Latagliata, Alfredo Molteni, Esther N. Oliva, Giuseppe A. Palumbo, Antonella Poloni, Prassede Salutari, Valeria Santini, Maria Teresa Voso & Pellegrino Musto. (2019) Infection control in patients with myelodysplastic syndromes who are candidates for active treatment: Expert panel consensus-based recommendations. Blood Reviews 34, pages 16-25.
Crossref
Christopher R. Cogle. (2015) Incidence and Burden of the Myelodysplastic Syndromes. Current Hematologic Malignancy Reports 10:3, pages 272-281.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.